Pulse Biosciences (PLSE) PT Raised to $30 at Oppenheimer Feb 20, 2026 06:22AM
Pulse Biosciences, Inc. (PLSE) Tops Q4 EPS by 7c Feb 19, 2026 04:13PM
Pulse Biosciences stock rises after positive cardiac catheter study data Feb 6, 2026 10:41AM
Mizuho Starts Pulse Biosciences (PLSE) at Outperform Jan 30, 2026 04:53AM
Pulse Biosciences receives FDA approval for atrial fibrillation study Dec 18, 2025 07:00AM


Dec 9, 2025 07:00AM Pulse Biosciences begins thyroid tumor research with MD Anderson Cancer Center
Oct 24, 2025 07:00AM Pulse Biosciences enrolls first patient in cardiac surgery study
Oct 10, 2025 07:00AM Pulse Biosciences presents cardiac surgical system study results at meeting
Sep 8, 2025 07:02AM Pulse Biosciences gets FDA approval for atrial fibrillation device study
Sep 2, 2025 07:03AM Pulse Biosciences completes first procedures in thyroid nodule study
Aug 26, 2025 07:01AM Pulse Biosciences publishes first-in-human thyroid nodule study data
Aug 15, 2025 10:45AM Pulse Biosciences, Inc. (PLSE) Mentioned as Short Again at White Diamond Research
Aug 12, 2025 04:05PM Pulse Biosciences, Inc. (PLSE) Reports Q2 Loss of $0.28
Jul 14, 2025 04:53PM Pulse Biosciences, Inc. (PLSE) Appoints Steven T. Weber as VP of Accounting and Global Corporate Controller
Jul 7, 2025 06:02AM Oppenheimer Starts Pulse Biosciences (PLSE) at Outperform
May 8, 2025 04:44PM Pulse Biosciences, Inc. (PLSE) Reports Q1 Loss of $0.25
Mar 27, 2025 04:09PM Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c
Feb 4, 2025 08:01AM Pulse Biosciences, Inc. (PLSE) Appoints Jon Skinner as CFO
Jan 21, 2025 07:01AM Pulse Biosciences (PLSE) Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
Jan 10, 2025 08:04AM Pulse Biosciences (PLSE) Appoints Paul LaViolette as Chief Executive Officer
Oct 31, 2024 02:25PM Pulse Biosciences (PLSE) Announces Positive Clinical Data Presented at the American Thyroid Association
Oct 30, 2024 04:13PM Pulse Biosciences, Inc. (PLSE) Tops Q3 EPS by 3c
Oct 30, 2024 04:03PM Pulse Biosciences, Inc. (PLSE) Appoints David Kenigsberg as Chief Medical Officer of Electrophysiology
Aug 12, 2024 04:02PM Pulse Biosciences (PLSE) Appoints Paul LaViolette to Its Board of Directors
Jul 8, 2024 08:09AM Pulse Biosciences (PLSE) Announces Receipt Of FDA Breakthrough Device Designation For Cellfx® Nspfa Cardiac Surgery System For The Treatment Of Atrial Fibrillation
Jun 28, 2024 08:00AM Pulse Biosciences (PLSE) Announces Preliminary Results for its Rights Offering